Non-association between 9.2 KB PvuII RFLP and seronegative spondyloarthropathies in Spain

Br J Rheumatol. 1992 Nov;31(11):743-6. doi: 10.1093/rheumatology/31.11.743.

Abstract

Several studies of DNA restriction fragment length polymorphism (RFLP) in ankylosing spondylitis (AS) have been carried out. The association between a recently identified class I HLA 9.2 kb PvuII RFLP and AS remain controversial. In order to evaluate this possible association in an Euro-Caucasian population, the genomic DNA of 42 AS patients and 18 patients with Reiter's syndrome (RS) and 42 healthy controls was analysed. Non-association between 9.2 kb PvuII RFLP and AS or RS was observed. As described previously, a strong association between this fragment and HLA-A3 and/or HLA-A9 antigens was demonstrated. A study of two families showed that this RFLP segregates with HLA-A3 and/or HLA-A9 and independently of the HLA-B27. Our findings support the view that the 9.2 kb PvuII fragment is not universally associated with AS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Reactive / genetics
  • Arthritis, Reactive / immunology
  • Deoxyribonucleases, Type II Site-Specific / genetics*
  • Female
  • HLA-B27 Antigen / analysis
  • Histocompatibility Antigens Class I / classification
  • Histocompatibility Antigens Class I / genetics*
  • Humans
  • Male
  • Polymorphism, Restriction Fragment Length*
  • Rheumatic Diseases / diagnosis
  • Rheumatic Diseases / genetics
  • Rheumatic Diseases / immunology*
  • Serologic Tests*
  • Spain
  • Spinal Diseases / diagnosis
  • Spinal Diseases / genetics
  • Spinal Diseases / immunology*
  • Spondylitis, Ankylosing / genetics
  • Spondylitis, Ankylosing / immunology

Substances

  • HLA-B27 Antigen
  • Histocompatibility Antigens Class I
  • CAGCTG-specific type II deoxyribonucleases
  • Deoxyribonucleases, Type II Site-Specific